PPARA and fatty liver disease: Moreover, the Ppara-/-, Acox1-/- double-knockout mice exhibit a few periportal clusters of steatotic hepatocytes, and (re-)expression of human ACOX1 in mice liver results in a substantial reduction in both PPARα activation and hepatic steatosis [8,180].